VICINITAS THERAPEUTICS

vicinitas-therapeutics-logo

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

#SimilarOrganizations #People #Financial #Event #Website #More

VICINITAS THERAPEUTICS

Industry:
Biotechnology Life Science Therapeutics

Founded:
2022-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.vicinitastx.com

Total Employee:
11+

Status:
Active

Total Funding:
65 M USD

Technology used in webpage:
Google Maps Amazon


Similar Organizations

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโ€‘based treatments for cardiovascular disease.

sonoma-biotherapeutics-logo

Sonoma BioTherapeutics

Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.


Current Advisors List

jorge-conde_image

Jorge Conde Board Member @ Vicinitas Therapeutics
Board_member
2022-07-01

george-golumbeski_image

George Golumbeski Board Member @ Vicinitas Therapeutics
Board_member
2022-07-01

cameron-wheeler_image

Cameron Wheeler Board Member @ Vicinitas Therapeutics
Board_member
2022-07-01

Current Employees Featured

christian-hofmann_image

Christian Hofmann
Christian Hofmann Chief Executive Officer & Board of Directors @ Vicinitas Therapeutics
Chief Executive Officer & Board of Directors
2023-04-01

adam-d-hughes_image

Adam D. Hughes
Adam D. Hughes Chief Scientific Officer @ Vicinitas Therapeutics
Chief Scientific Officer
2024-04-01

daniel-nomura_image

Daniel Nomura
Daniel Nomura Founder, Scientific Adviser, and Board Member @ Vicinitas Therapeutics
Founder, Scientific Adviser, and Board Member
2022-05-01

Founder


daniel-nomura_image

Daniel Nomura

Investors List

berkeley-catalyst-fund-bcf_image

Berkeley Catalyst Fund (BCF)

Berkeley Catalyst Fund (BCF) investment in Series A - Vicinitas Therapeutics

the-mark-foundation-for-cancer-research_image

The Mark Foundation for Cancer Research

The Mark Foundation for Cancer Research investment in Series A - Vicinitas Therapeutics

droia_image

Droia Ventures

Droia Ventures investment in Series A - Vicinitas Therapeutics

google-ventures_image

Google Ventures

Google Ventures investment in Series A - Vicinitas Therapeutics

andreessen-horowitz_image

Andreessen Horowitz

Andreessen Horowitz investment in Series A - Vicinitas Therapeutics

deerfield_image

Deerfield

Deerfield investment in Series A - Vicinitas Therapeutics

Official Site Inspections

http://www.vicinitastx.com

  • Host name: server-18-160-10-61.iad12.r.cloudfront.net
  • IP address: 18.160.10.61
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vicinitas Therapeutics"

Home - Vicinitas Therapeutics

The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Our vision is to use our proprietary โ€ฆSee details»

Vicinitas Therapeutics - Crunchbase Company Profile

Jul 28, 2022ย ยท Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of โ€ฆSee details»

Our Team - Vicinitas Therapeutics

Christian Hofmann is the CEO of Vicinitas Therapeutics. He brings more than two decades of biopharma strategy and business development experience across all stages of development to โ€ฆSee details»

Vicinitas Therapeutics Launches With $65 Million in โ€ฆ

Jul 28, 2022ย ยท SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in...See details»

Vicinitas Therapeutics - LinkedIn

Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers known as Deubiquitinase Targeting Chimeras (DUBTACs).See details»

Vicinitas Therapeutics - Craft

Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers. It specializes in small-molecule drugs and therapies for cancer and monogenic diseases. Also, โ€ฆSee details»

News - Vicinitas Therapeutics

Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat DiseaseSee details»

About Vicinitas Therapeutics - Droia Ventures โ€“ Investing in Impact

Jul 28, 2022ย ยท SOUTH SAN FRANCISCO, JULY 28, 2022 โ€“ Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to โ€ฆSee details»

Vicinitas Therapeutics Launches With $65 Million in Series A โ€ฆ

Jul 28, 2022ย ยท SOUTH SAN FRANCISCO, JULY 28, 2022 โ€“ Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to โ€ฆSee details»

Vicinitas Therapeutics Company Profile: , Investments, Contact ...

Vicinitas Therapeutics is a targeted protein stabilization company developing next-generation drugs that stabilize the levels of aberrantly degraded proteins in disease. https://vicinitastx.comSee details»

Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief ...

May 9, 2023ย ยท Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers known as Deubiquitinase Targeting Chimeras (DUBTACs).See details»

Vicinitas Therapeutics - Berkeley Startup Cluster

Their vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic โ€ฆSee details»

Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief ...

May 9, 2023ย ยท Dr. Hofmann brings to Vicinitas more than two decades of biopharma business and portfolio planning experience across all stages of development. Hofmann joins Vicinitas from โ€ฆSee details»

Vicinitas Therapeutics CEO and Key Executive Team | Craft.co

Vicinitas Therapeutics's key executives include Joe Budman and 8 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via โ€ฆSee details»

Vicinitas Therapeutics - VentureRadar

Website: http://www.vicinitastx.com. Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilizers known as Deubiquituinase Targeting Chimeras (DUBTACs).See details»

Vicinitas Therapeutics - VentureRadar

Website: http://www.vicinitastx.com Develops targeted protein stabilizers, Deubiquituinase Targeting Chimeras (DUBTACs), to address critical human health issues and create next โ€ฆSee details»

Vicinitas Therapeutics - Overview, News & Similar companies

May 9, 2023ย ยท View Vicinitas Therapeutics (www.vicinitastx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Vicinitas Therapeutics | Insights

Sep 5, 2022ย ยท Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Working at Vicinitas Therapeutics - Glassdoor

See what employees say it's like to work at Vicinitas Therapeutics. Salaries, reviews, and more - all posted by employees working at Vicinitas Therapeutics.See details»

Election Manager - Simply Voting

Welcome to the Election Manager. Please enter your organization's voting website.See details»

linkstock.net © 2022. All rights reserved